iVeena

About:

iVeena develops ocular drug products that eliminate the need for eye drop application and painful injections.

Top Investors: National Science Foundation, Mountain Pacific Partners, Park City Angels, Technology Venture Corporation, PC Squared, LLC

Description:

iVeena has five products in the late pre-clinical and research phases. Targeted indications include post-surgery cataract inflammation, macular degeneration (Wet AMD), diabetic retinopathy, and glaucoma. iVeena Delivery Systems, Inc. was founded in 2006 by Bala Ambati and is based in Salt Lake City, Utah.

Total Funding Amount:

$4.27M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Salt Lake City, Utah, United States

Founded Date:

2006-01-01

Founders:

Bala Ambati

Number of Employees:

1-10

Last Funding Date:

2020-07-08

IPO Status:

Private

Industries: